Dr. Samer Taha is the CEO and co-founder of H2MOF and has more than 20 years of experience in R&D, technology commercialization and entrepreneurship in ICT and Nanotechnology.

In 2018, Dr. Taha was appointed Executive Chairman of Revonence Technologies International, a value-add private equity holding group, where he shifted the focus of the group toward Greentech and Nanotechnology commercialization. Since 2018, he co-founded new startups and established research collaboration programs with several leading research institutes including Northwestern University, University of California Berkeley, and University of Texas Dallas.

Between the years 2018 and 2020, Dr. Taha worked closely with Nobel Laureate, Professor Fraser Stoddart, and his team of scientists, on the scaling and commercialization of the CD-MOFs (Cyclodextrin-Based Metal-Organic Frameworks) technology, the only edible and biodegradable MOF known to date. He also led the development of a manufacturing facility for the large-scale synthesis, activation, and integration of the organic nanotechnology CD-MOF.